Cerebral Infarction
Pipeline by Development Stage
On Market (2)
Approved therapies currently available
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 18 trials with date data
Clinical Trials (18)
Total enrollment: 23,597 patients across 18 trials
A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial
Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function
Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease
CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease
Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation
CASTLE (Clopidogrel And Serum Troponin Level Elevation)
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Aortic Arch Related Cerebral Hazard Trial (ARCH)
Warfarin and Antiplatelet Therapy in Chronic Heart Failure
Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56
Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)
Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
Mixed Antagonist of Serotonin for Claudication Optimal Therapy
Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
PPI and Clopidogrel Response
Chinese Assessment for Vinpocetine In Neurology